Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.
B cell depletion therapy using rituximab has been shown to be effective in achieving remission in patients with HCV-mixed cryoglobulinemic (MC) vasculitis. Previously, we have demonstrated abnormalities in peripheral immune cells involving neutrophils, chemotaxis, and innate immune activation among...
Main Authors: | Emily Comstock, Cheol-Woo Kim, Alison Murphy, Benjamin Emmanuel, Xi Zhang, Michael Sneller, Bhawna Poonia, Shyamasundaran Kottilil |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5724854?pdf=render |
Similar Items
-
Lymphocyte Landscape after Chronic <i>Hepatitis C Virus</i> (HCV) Cure: The New Normal
by: Alip Ghosh, et al.
Published: (2020-10-01) -
Immune Correlates of COVID-19 Control
by: Bhawna Poonia, et al.
Published: (2020-09-01) -
Immunopathogenic mechanisms of enteropathy in Africans
by: Veitch, Andrew McCulloch
Published: (2000) -
HCV-RELATED VASCULITIS
by: Shafiq Ahmad Joya, et al.
Published: (2021-07-01) -
Peripheral PD-1+ T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
by: Sara Romani, et al.
Published: (2019-06-01)